|
|
|
CGIX - Cancer Genetics, Inc.
Cancer
Genetics, Inc. (CGIX) is a company focused on developing and
commercializing innovative genomic-based diagnostic tests and
services. Their products and services are designed to provide patients
and physicians with better information for the diagnosis, prognosis,
and treatment of cancer.
Cancer Genetics' proprietary
technologies and tests are based on the analysis of cancer-related
genes and biomarkers. They offer a range of tests for various cancers,
including hematological malignancies, solid tumors, and women's
cancers. These tests provide clinicians with valuable information that
can help guide treatment decisions.
The company also provides a
range of biopharma services, including biomarker discovery, assay
development, clinical trial support, and companion diagnostic
development. Their customers include biotech and pharmaceutical
companies, as well as academic and research institutions.
Cancer Genetics hass a strong pipeline of products in development,
including several new diagnostic tests for different types of cancer.
They are also exploring new applications for their existing tests and
technologies.
In summary, Cancer Genetics is a company that is
leveraging the power of genomics to provide innovative diagnostic
tests and services for cancer patients. With a strong pipeline of
products in development and a growing list of customers, they are
well-positioned for future growth in this impor
|
|
|
|
|
